| socazolimab (STI-A1014) / Sorrento |
ChiCTR1800016649: Phase I+II clinical study protocol of recombinant human anti-PD-L1 monoclonal antibody (ZKAB001) |
|
|
| Not yet recruiting | 1 | 21 | | Intravenous infusion ;Intravenous infusion ;Intravenous infusion | the Sixth People's Hospital; Zhaoke (Guang Zhou) Oncology Pharmaceutical Limited, Self-finacing | Osteosarcoma | | | | |
NCT03676959: A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer |
|
|
| Recruiting | 1 | 101 | RoW | ZKAB001 5mg/kg, PD-L1 monoclonal antibody, ZKAB001 10mg/kg, ZKAB001 15mg/kg | Lee's Pharmaceutical Limited | Cervical Cancer | 05/22 | 10/22 | | |
NCT04603846: A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma |
|
|
| Active, not recruiting | 1 | 20 | RoW | anti-PD-L1 antibody, ZKAB001, albumin bound paclitaxel, ABRAXANE | Lee's Pharmaceutical Limited | Advanced Urothelial Carcinoma | 10/22 | 08/23 | | |
NCT04346914: Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer |
|
|
| Recruiting | 1 | 20 | RoW | recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide | Lee's Pharmaceutical Limited | Extensive Stage Small Cell Lung Cancer | 10/22 | 10/22 | | |
NCT04608786: A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer |
|
|
| Enrolling by invitation | 1 | 10 | RoW | ZKAB001 5mg/kg, PD-L1 monoclonal antibody, Capecitabine | Lee's Pharmaceutical Limited | Biliary Tract Cancer | 12/22 | 12/23 | | |
ChiCTR2100042988: A single-arm, open phase Ib clinical study of ZKAB001 combined with capecitabine for adjuvant treatment of patients with malignant tumors of the biliary system |
|
|
| Recruiting | 1 | 10 | | Regiments | Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University; Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Guangzhou Zhaoke Pharmaceutical Co., Ltd. | Malignant tumor of biliary system | | | | |
